Product Details
Imcivree
Setmelanotide (Setmelanotide Acetate)10 mg/mL
Solution for Subcutaneous Injection
1-mL Multiple-Dose Vial
DIN/PIN/NPN
02537745
Manufacturer
Rhythm Pharmaceuticals Inc.
Formulary Listing Date
2025-10-10
Unit Price
4022.9046
Amount MOH Pays
4022.9046
Coverage Status
Exceptional Access Program Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
A08AA12
Interchangeable Products
NOLU Clinical Criteria
NORequirements
EAP Criteria
| Therapeutic Class | Reimbursement Criteria |
|---|---|
| Unclassified EAP Drugs | These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – January 1, 2025 Edition Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding. |